Irina Apostolou
Corporate Officer/Principal at CONSTELLATION PHARMACEUTICALS, INC.
Profile
She is an immunologist by training and an accomplished drug discovery and translational research leader with over 13 years of cross-functional leadership roles in large pharma and biotech in the therapeutic areas of Immuno-Oncology, Autoimmunity, Inflammation and Oncology.
Irina has a deep experience in developing and executing strategies for target mining, selection, validation, and at advancing drug programs from discovery to in vitro and in vivo proof-of concept, PK/PD, and safety pharmacology studies.
Throughout her professional experience in the pharmaceutical industry, she has acquired an extensive experience working with and forging successful, long-term relationships with academic investigators, and is well-versed in conducting scientific and technical due diligence and assessment for partnering, investing, and licensing opportunities.
As part of the OTD Alliance Corporate Team, Irina serves as the primary scientific liaison between Harvard OTD and the Alliance partner to spearhead the identification of projects.
She works closely with Harvard faculty and their research teams to develop project proposals that bridge the gap between basic research and the drug development process, and manages project execution in collaboration with Harvard faculty.
Irina earned her B.Sc.
in Molecular Biology & Genetics, M.Sc.
in Cellular & Molecular Genetics, and Ph.D.
in Genetics & Immunology from the Paris-Sud University in France.
She was also a Research Fellow and an Instructor in Pathology at Harvard Medical School.
Irina Apostolou active positions
Companies | Position | Start |
---|---|---|
CONSTELLATION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-07-31 |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Corporate Officer/Principal | - |
Former positions of Irina Apostolou
Companies | Position | End |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 2016-07-30 |
Training of Irina Apostolou
Institut Universitaire de Technologie de Cachan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private companies | 2 |
---|---|
Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Office of Technology Development
Office of Technology Development Investment ManagersFinance Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Stock Market
- Insiders
- Irina Apostolou